These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 19930174

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer.
    Reed AB, Parekh DJ.
    Curr Opin Urol; 2009 May; 19(3):238-42. PubMed ID: 19318950
    [Abstract] [Full Text] [Related]

  • 4. Effect of finasteride on risk of prostate cancer: how little we really know.
    Rubin MA, Kantoff PW.
    J Cell Biochem; 2004 Feb 15; 91(3):478-82. PubMed ID: 14755678
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prostate cancer prevention and finasteride.
    D'Amico AV, Barry MJ.
    J Urol; 2006 Nov 15; 176(5):2010-2; discussion 2012-3. PubMed ID: 17070238
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Finasteride decreases the risk of prostatic intraepithelial neoplasia.
    Thompson IM, Lucia MS, Redman MW, Darke A, La Rosa FG, Parnes HL, Lippman SM, Coltman CA.
    J Urol; 2007 Jul 15; 178(1):107-9; discussion 110. PubMed ID: 17499284
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The PCPT trial].
    Hamdy FC, Rouprêt M.
    Prog Urol; 2008 Apr 15; 18 Suppl 3():S40-3. PubMed ID: 18455082
    [Abstract] [Full Text] [Related]

  • 11. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.
    Thompson IM, Chi C, Ankerst DP, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA.
    J Natl Cancer Inst; 2006 Aug 16; 98(16):1128-33. PubMed ID: 16912265
    [Abstract] [Full Text] [Related]

  • 12. Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes.
    Lotan Y, Cadeddu JA, Lee JJ, Roehrborn CG, Lippman SM.
    J Clin Oncol; 2005 Mar 20; 23(9):1911-20. PubMed ID: 15774783
    [Abstract] [Full Text] [Related]

  • 13. Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.
    Etzioni RD, Howlader N, Shaw PA, Ankerst DP, Penson DF, Goodman PJ, Thompson IM.
    J Urol; 2005 Sep 20; 174(3):877-81. PubMed ID: 16093979
    [Abstract] [Full Text] [Related]

  • 14. A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits.
    Montorsi F, Alcaraz A, Desgrandchamps F, Hammerer P, Schröder F, Castro R.
    Prostate; 2009 Jun 01; 69(8):895-907. PubMed ID: 19267353
    [Abstract] [Full Text] [Related]

  • 15. High-grade prostate cancer and the prostate cancer prevention trial.
    Logothetis CJ, Schellhammer PF.
    Cancer Prev Res (Phila); 2008 Aug 01; 1(3):151-2. PubMed ID: 19138948
    [No Abstract] [Full Text] [Related]

  • 16. Estimated impact of the Prostate Cancer Prevention Trial on population mortality.
    Unger JM, Thompson IM, LeBlanc M, Crowley JJ, Goodman PJ, Ford LG, Coltman CA.
    Cancer; 2005 Apr 01; 103(7):1375-80. PubMed ID: 15739207
    [Abstract] [Full Text] [Related]

  • 17. Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited.
    Klein EA, Tangen CM, Goodman PJ, Lippman SM, Thompson IM.
    J Clin Oncol; 2005 Oct 20; 23(30):7460-6. PubMed ID: 16157937
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Quantifying the impact of prostate volumes, number of biopsy cores and 5alpha-reductase inhibitor therapy on the probability of prostate cancer detection using mathematical modeling.
    Serfling R, Shulman M, Thompson GL, Xiao Z, Benaim E, Roehrborn CG, Rittmaster R.
    J Urol; 2007 Jun 20; 177(6):2352-6. PubMed ID: 17509357
    [Abstract] [Full Text] [Related]

  • 20. Do the benefits of finasteride outweigh the risks in the prostate cancer prevention trial?
    Grover S, Lowensteyn I, Hajek D, Trachtenberg J, Coupal L, Marchand S.
    J Urol; 2006 Mar 20; 175(3 Pt 1):934-8; discussion 938. PubMed ID: 16469585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.